Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma

Table 1

Comparison between the present case report and the others reported in the literature.

	Age	Sex	Risk factors	Tumor	Cancer treatment	Dose of cancer treatment	Timing of symptoms development	CT scan evidence	Treatment of ILD	Outcome
Mazzotta et al.	77 y	F	Systemic sclerosis; thoracic radiation therapy	Angiosarcoma	PLD	PLD: 40 mg/m^2 d1 q28	8 weeks after the first administration	Confluent bilateral ground glass areas	Steroids and antibiotics	Fatal
Huober et al. [4]	53 y	F	None	Breast cancer	PLD + Bevacizumab	PLD: 20 mg/m^2 d1 q14; Bevacizumab: 10 mg/m^2 d1 q14	6 weeks after the first administration	Ground glass areas	Steroids	Resolved
Mark and Thürlimann [5]	70 y	F	Previous chemotherapy; thoracic radiation therapy	Breast cancer	PLD	PLD: 20 mg/m^2 d1 q14	6 weeks after the first administration	Bilaterally pronounced alveolitic changes	Steroids and antibiotics	Fatal
Inaba et al. [6]	48 y	F	Previous chemotherapy	Ovarian cancer	PLD	PLD: 50 mg/m^2 d1 q28	8 weeks after the first administration	Ground glass areas	Steroids and antibiotics	Resolved
Nevadunsky et al. [7]	57 y	F	Previous chemotherapy	Uterine papillary serous carcinoma	PLD	PLD: 40 mg/m^2 d1 q28	12 weeks after the first administration	Diffuse airspace disease	Steroids and antibiotics	Fatal